Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Logothetis

Showing results (281-290 of 383) with videos related to

Pageof 39
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
Molecular Cancer Research : MCR|August 19, 2008
Cadherin-11 promotes the metastasis of prostate cancer cells to boneKhoi Chu, Chien-Jui Cheng, Xiangcang Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2015
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptorsJami Mandelin, Marina Cardó-Vila, Wouter H P Driessen, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
Oncogene|May 21, 2008
A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formationS-H Lin, C-J Cheng, Y-C Lee, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Cancer Research|July 8, 2022
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast TransitionGuoyu Yu, Paul G Corn, Pengfei Shen, et al.
Research Square|August 7, 2024
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.
Iscience|May 13, 2021
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4Guoyu Yu, Pengfei Shen, Yu-Chen Lee, et al.
Cell|August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionChia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Pageof 39

Showing results (281-290 of 383) with videos related to

Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
Molecular Cancer Research : MCR|August 19, 2008
Cadherin-11 promotes the metastasis of prostate cancer cells to boneKhoi Chu, Chien-Jui Cheng, Xiangcang Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2015
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptorsJami Mandelin, Marina Cardó-Vila, Wouter H P Driessen, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
Oncogene|May 21, 2008
A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formationS-H Lin, C-J Cheng, Y-C Lee, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Cancer Research|July 8, 2022
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast TransitionGuoyu Yu, Paul G Corn, Pengfei Shen, et al.
Research Square|August 7, 2024
Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone TherapyEfstratios Koutroumpakis, Rushin Patel, Sumanth Khadke, et al.
Iscience|May 13, 2021
Multiple pathways coordinating reprogramming of endothelial cells into osteoblasts by BMP4Guoyu Yu, Pengfei Shen, Yu-Chen Lee, et al.
Cell|August 6, 2013
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionChia-Hsin Chan, John Kenneth Morrow, Chien-Feng Li, et al.
Pageof 39